PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies

2024-05-16
(Press-News.org) Scientists have made several advances in the design of a class of HIV vaccines that could offer broad protection against the virus, according to four new research papers published this week in Science, Science Translational Medicine, and Science Immunology. “The studies […] exemplify progress in the rational design of [germline-targeting] HIV-1 vaccines, and what is being learned will guide [germline-targeting] programs for inducing [broadly neutralizing antibodies] against other human pathogens,” Rogier Sanders and John Moore write in a related Perspective on the new articles. As the HIV epidemic enters its fifth decade, scientists have poured time and resources into developing vaccine candidates for the virus. However, health authorities still lack a working, approved vaccine that induces broadly neutralizing antibodies, which can neutralize the most common circulating strains of HIV. One solution involves a process called germline targeting, where scientists use a series of proteins targeted by the immune system (immunogens) to shepherd and “prime” young B cells as they mature in sites called germinal centers, with the goal of coaxing the cells to produce broadly neutralizing antibodies against HIV. In the first paper in Science, Jon Steichen and colleagues tested the protective effects of a new germline-targeting strategy based on the N332-GT5 trimer, a component of the HIV viral envelope. Leveraging cryo-electron microscopy, the team showed that their approach successfully primed and boosted quantities of B cells that secret precursors to BG18 – an anti-HIV broadly neutralizing antibody – in a group of eight rhesus macaques. Taking a different delivery approach in the second Science study, Zhenfei Xie and colleagues demonstrated they could prime B cells with N332-GT5 via mRNA, which they delivered via lipid nanoparticles. When given to humanized mice, the mRNA delivered both the primary immunogen (N332-GT5) and two additional immunogens that further primed the target B cells. Together, these immunogens kickstarted the activation and expansion of B cells that secreted precursors to BG18, with Xie et al. hypothesizing that their strategy could reduce undesirable off-target binding. Meanwhile, in a study in Science Translational Medicine, Christopher Cottrell and colleagues designed a new nanoparticle immunogen as a boost to germline-targeting HIV vaccines. They first primed mice with an immunogen named eOD-Gt8 60mer, which was previously found to induce precursors to anti-HIV, VRC01-class broadly neutralizing antibodies in a phase 1 trial. After priming, Cottrell et al. then vaccinated mice with another immunogen named core-g28v2 60mer (in both protein and mRNA form) as a “first boost.” They found that this prime-boost approach elicited VRC01-class antibodies that were precursors to broadly neutralizing antibodies and neutralized HIV-like pseudoviruses in culture. Finally, in a study in Science Immunology, Xuesong Wang and colleagues showed that they could deliver eOD-Gt8 60mer as an initial priming immunogen via mRNA encapsulated in lipid nanoparticles. The researchers transferred several different humanized B cell lines into mice to mimic the competition between B cells that occurs during immunization. Their priming strategy coaxed B cells to diversify, participate in germinal centers, and acquire mutations and characteristics needed to secrete VRC01-class antibodies. In their related Perspective, Sanders and Moore add that the results provide a strong proof-of-concept for promising germline-targeting approaches, noting that the N332-GT5 trimer is now in a phase 1 trial.

END


ELSE PRESS RELEASES FROM THIS DATE:

Total energy cost of animal reproduction is higher than previously assumed

2024-05-16
The energy invested in animal reproduction is as much as 10 times greater than previously estimated when the metabolic load of bearing and caring for offspring is accounted for, according to a new study. The findings fundamentally challenge longstanding theories and biological models of animal growth and life histories. The act of reproduction is one of the largest energy investments an animal can make. This investment includes direct cost, the energy directly invested in the offspring themselves, and indirect costs, the energy expended to create, carry, and care for offspring before they are born. While the direct costs of reproduction are well understood, the indirect ...

Researchers discover new pathway to cancer cell suicide

Researchers discover new pathway to cancer cell suicide
2024-05-16
Researchers discover new pathway to cancer cell suicide Chemotherapy kills cancer cells. But the way these cells die appears to be different than previously understood. Researchers from the Netherlands Cancer Institute, led by Thijn Brummelkamp, have uncovered a completely new way in which cancer cells die: due to the Schlafen11 gene. "This is a very unexpected finding. Cancer patients have been treated with chemotherapy for almost a century, but this route to cell death has never been observed before. Where and when this occurs in patients will need to be further investigated. This discovery could ultimately have implications for the treatment of cancer patients." They publish their ...

Researchers wrestle with accuracy of AI technology used to create new drug candidates

Researchers wrestle with accuracy of AI technology used to create new drug candidates
2024-05-16
CHAPEL HILL, N.C. – Artificial intelligence (AI) has numerous applications in healthcare, from analyzing medical imaging to optimizing the execution of clinical trials, and even facilitating drug discovery. AlphaFold2, an artificial intelligence system that predicts protein structures, has made it possible for scientists to identify and conjure an almost infinite number of drug candidates for the treatment of neuropsychiatric disorders. However recent studies have sown doubt about the accuracy of AlphaFold2 in modeling ligand binding sites, the areas on proteins where drugs attach and begin signaling ...

Breaking bonds to form bonds: Rethinking the Chemistry of Cations

Breaking bonds to form bonds: Rethinking the Chemistry of Cations
2024-05-16
A team of chemists from the University of Vienna, led by Nuno Maulide, has achieved a significant breakthrough in the field of chemical synthesis, developing a novel method for manipulating carbon-hydrogen bonds. This groundbreaking discovery provides new insights into the molecular interactions of positively charged carbon atoms. By selectively targeting a specific C–H bond, they open doors to synthetic pathways that were previously closed – with potential applications in medicine. The study was recently published in the prestigious journal Science. Living ...

New gene delivery vehicle shows promise for human brain gene therapy

2024-05-16
In an important step toward more effective gene therapies for brain diseases, researchers from the Broad Institute of MIT and Harvard have engineered a gene-delivery vehicle that uses a human protein to efficiently cross the blood-brain barrier and deliver a disease-relevant gene to the brain in mice expressing the human protein. Because the vehicle binds to a well-studied protein in the blood-brain barrier, the scientists say it has a good chance at working in patients. Gene therapy could potentially treat a range of severe genetic brain disorders, which currently ...

Finding quantum order in chaos

2024-05-16
If you zoom in on a chemical reaction to the quantum level, you’ll notice that particles behave like waves that can ripple and collide. Scientists have long sought to understand quantum coherence, the ability of particles to maintain phase relationships and exist in multiple states simultaneously; this is akin to all parts of a wave being synchronized. It has been an open question whether quantum coherence can persist through a chemical reaction where bonds dynamically break and form. Now, for the first time, a team of Harvard scientists has demonstrated the survival of quantum coherence in a chemical reaction involving ultracold molecules. These findings highlight the potential of ...

Study suggests high-frequency electrical ‘noise’ results in congenital night blindness

Study suggests high-frequency electrical ‘noise’ results in congenital night blindness
2024-05-16
In what they believe is a solution to a 30-year biological mystery, neuroscientists at Johns Hopkins Medicine say they have used genetically engineered mice to address how one mutation in the gene for the light-sensing protein rhodopsin results in congenital stationary night blindness. The condition, present from birth, causes poor vision in low-light settings. The findings, published May 14 in Proceedings of the National Academy of Sciences, demonstrate that the rhodopsin gene mutation, called ...

TeltoHeart wristband, developed by Lithuanians, receives important medical device certification

TeltoHeart wristband, developed by Lithuanians, receives important medical device certification
2024-05-16
Teltonika’s TeltoHeart, a multifunctional smart wristband system developed in cooperation between Lithuanian industry and universities has been given the CE MDR (Class IIa) medical device certification. This approval confirms that the product meets the comprehensive quality standards for medical devices and opens up new markets worldwide for this innovative product. "This is an important recognition that we have been working towards since the start of this project in 2020. The CE MDR certification proves that TeltoHeart is a safe ...

Unique brain circuit is linked to Body Mass Index

2024-05-16
·  One region is related to olfaction and reward, the other to negative feelings like pain  ·  When the connection between these brain regions is weak, people have higher BMI ·  Food may continue to be rewarding, even when these individuals are full CHICAGO --- Why can some people easily stop eating when they are full and others can’t, which can lead to obesity? A Northwestern Medicine study has found one reason may be a newly discovered structural connection ...

Noise survey highlights need for new direction at Canadian airports #ASA186

Noise survey highlights need for new direction at Canadian airports #ASA186
2024-05-16
OTTAWA, Ontario, May 16, 2024 – The COVID-19 pandemic changed life in many ways, including stopping nearly all commercial flights. At the Toronto Pearson International Airport, airplane traffic dropped by 80% in the first few months of lockdown. For a nearby group of researchers, this presented a unique opportunity. Julia Jovanovic will present the results of a survey conducted on aircraft noise and annoyance during the pandemic era Thursday, May 16, at 11:10 a.m. EDT as part of a joint meeting of the Acoustical Society of America and ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies